Stocks Hitting 52-Week Highs

Durata Therapeutics DRTX shares reached a new 52-week high of $23.66 after Actavis ACT announced its plans to buy Durata Therapeutics for around $616.4 million. Chimerix CMRX shares jumped 8.84% to touch a new 52-week high of $32.72 after the company reported the emergency investigational NDA for brincidofovir authorized by the FDA. CareFusion CFN shares gained 23.13% to touch a new 52-week high of $56.85 after Becton Dickinson & Co BDX announced its plans to acquire CareFusion for $12.2 billion in cash and stock. Becton, Dickinson and Company BDX shares rose 6.47% to reach a new 52-week high of $123.34 on announcement of CareFusion acquisition.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsIntraday UpdateMarketsMovers52 Week Highs52-Week Highs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!